Author Correction: Molecular bottlebrush prodrugs as mono- and triplex combination therapies for multiple myeloma

Nat Nanotechnol. 2023 Apr;18(4):419. doi: 10.1038/s41565-023-01345-y.

Alexandre Detappe^#^{1

2

3}, Hung V-T Nguyen^#^{1

2

4

5}, Yivan Jiang^{4

5}, Michael P Agius^{1

2}, Wencong Wang⁴, Clelia Mathieu^{1

2}, Nang K Su^{1

2}, Samantha L Kristufek⁴, David J Lundberg⁶, Sachin Bhagchandani⁶, Irene M Ghobrial^{7

8}, P Peter Ghoroghchian^{9

10}, Jeremiah A Johnson^{11

12

13}

¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
² Harvard Medical School, Boston, MA, USA.
³ Institut de Cancérologie Strasbourg Europe, Strasbourg, France.
⁴ Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.
⁵ Window Therapeutics, Boston, MA, USA.
⁶ Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
⁷ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Irene_Ghobrial@dfci.harvard.edu.
⁸ Harvard Medical School, Boston, MA, USA. Irene_Ghobrial@dfci.harvard.edu.
⁹ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. ppg@mit.edu.
¹⁰ Harvard Medical School, Boston, MA, USA. ppg@mit.edu.
¹¹ Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA. jaj2109@mit.edu.
¹² Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. jaj2109@mit.edu.
¹³ Broad Institute of MIT and Harvard, Cambridge, MA, USA. jaj2109@mit.edu.

^# Contributed equally.

No abstract available

Publication types